GoodRx Holdings (GDRX) Free Cash Flow (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Free Cash Flow data on file, last reported at $10.7 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 186.86% year-over-year to $10.7 million; the trailing twelve-month figure through Mar 2026 stood at $120.4 million (down 6.03% YoY), and the FY2025 full-year result was $97.4 million, down 46.67% from the prior year.
• Free Cash Flow declined to $10.7 million in Q1 2026, from $18.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $123.0 million in Q3 2024 to a low of -$27.1 million in Q2 2024.
• A 5-year average of $33.6 million and a median of $31.7 million in 2022 frame the typical range for Free Cash Flow.
• Peak annual rise in Free Cash Flow reached 566.41% in 2024, while the deepest fall reached 162.11% in 2024.
• Tracing GDRX's Free Cash Flow over 5 years: stood at $31.7 million in 2022, then jumped by 79.91% to $57.1 million in 2023, then declined by 21.9% to $44.6 million in 2024, then slumped by 58.95% to $18.3 million in 2025, then plunged by 41.52% to $10.7 million in 2026.
• Business Quant data shows GDRX's Free Cash Flow at $10.7 million in Q1 2026, $18.3 million in Q4 2025, and $59.8 million in Q3 2025.